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Abstract
Background: The use of non-drug, non-health-service interventions has been proposed as a cost-effective
alternative to help those with long-term conditions manage their illness and improve their health and well-being.
Interventions typically involve accessing activities run by the third sector or community agencies and may also be
described as non-medical referral, community referral or social prescribing. To be effective, patients need to be
“transferred” from the primary care setting into the community and to maintain their participation in activities.
However, it is not currently known how and why these approaches enable which people under what
circumstances to reach community services that may benefit their health and well-being.
Methods: Database searches and extensive searching of grey sources will be carried out in an attempt to find
evidence associated with referral and retention in social prescribing. After initial scoping searches, two main phases
of searching will be conducted: (a) will focus on the identification of programme theories to illustrate how
approaches to social prescribing work for different people and in different contexts and (b) will consist of targeted
searches to locate evidence to refine these candidate theories into configurations of the contexts in which
populations and the main mechanisms outcomes are achieved. Inclusion criteria will initially be broad in order to
develop a clear picture of the ways in which social prescriptions might operate but may iteratively become more
focused in response to initially identified evidence, for example, in terms of the population group.
An expert advisory group consisting of professionals working in a range of organisations involved in social
prescribing will be convened to check the approaches in the review and provide real-life experience of social
prescribing. Findings from the review will be disseminated to commissioners, published in a peer-reviewed journal
and used to help refine an intervention model for an outdoor nature-based group intervention.
Discussion: This realist review will explore why mechanisms of social prescribing work, for what groups of people
and their impact on enrolment, attendance and adherence to programmes. The use of realist approaches to detail
the social prescribing process is novel and will offer insights into effective transfer of patients.
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Background
The use of non-drug, non-health-service interventions
has been proposed as a cost-effective alternative to help
those with long-term conditions manage their condition
and improve their health and well-being [1], contribut-
ing to the global “Triple Aim” by applying integrated
approaches to simultaneously improve care, improve
population health, and reduce costs per capita [2]. Typ-
ically, this involves accessing activities run by the third
sector or community agencies and is described as non-
medical referral, community referral or social prescrib-
ing1 [3]. As of yet, there is no agreed definition of social
prescribing [4]. Patients may self-refer or be referred
through a healthcare or other professionals. A wide
range of social prescription activities have been devel-
oped, including art therapy, walking groups, reading
groups, nature-based activities and volunteering [5].
These are multi-component, complex interventions and
are similar to more established exercise referral schemes
[6–8]. Mild to moderate depression is one condition that
may benefit from social prescribing, particularly as the
third most common reason for general practice consul-
tations in the UK is depression [9]. Approximately 1 in
20 people experience an episode of depression each year,
with one quarter of women and 1 in 10 men requiring
treatment for it at some point over their lifetime [9].
The causes of depression can be wide-ranging, with
symptoms including social isolation, a decrease in activ-
ity, sleep disturbances, incapacity to work, poor concen-
tration and poor eating habits [10].
Social prescribing interventions potentially enable
healthcare providers to respond to a more holistic range
of patient needs, reduce frequency of attendance to GPs,
reduce social isolation and aid return to work. It is also
argued that social prescription models extend the trad-
itional boundaries of primary care and facilitate oppor-
tunities for contact with dedicated professionals with
increased time allocation and more specific expertise
[11–14]. The current health policy and guidance, such
as the English NHS’s Five Year Forward View [15] and
the Social Value Act [16], are supportive of the types of
mechanisms and approaches inherent to social prescrib-
ing models.
For social prescription interventions to be successful,
patients need to be successfully “transferred” from the
primary care setting to the relevant resource and to
maintain participation for an appropriate period of time.
By primary care, we include community mental health
and general practice services. The routes through which
people are referred are likely to influence the uptake of
these services and therefore their success. For instance,
without an appropriate, supportive structure for this
transition, the suggestion (i.e. referral) to pursue an ac-
tivity is unlikely to be taken up by the patient [4, 17].
Workshops hosted by Bromley PCT established the fol-
lowing six models of transfer [4, 5]:
1. Information service—this is an information-only
service, with display boards and directory access.
There is no face-to-face contact.
2. Information and telephone line—leaflets and notice
boards advertise the service, and patients self-initiate
a telephone discussion with a worker. Again, there is
no face-to-face contact.
3. Primary care referral—primary healthcare workers
assess patients and refer them to a social prescribing
service. This is based upon an appointment leading
onto non-clinical issues and is opportunistic.
4. Practice-based generic referral worker—groups are
held in general practice, and patients can be referred
by health workers or self-refer. This may mean that
there is a process of triage and signposting. The
surgery can act as a “one-stop shop”.
5. Practice-based specialist referral worker—as above
the specialist, worker works from primary care
practices but may offer specific services such as
Citizens Advice. Direct advice may then be offered
as well as referral or signposting onwards.
6. Non-primary care based—referrals from
practice-based staff are sent to a referral centre
(Bromley User Group Outreach Centre). This
could be an outreach service, set in the community,
offering a one-to-one service. Other organisations also
use this service and facilities.
Others have suggested that effective delivery would
need to consider the following: “link” workers, re-
source directories, developing of primary care organ-
isational links, increased referrals to organisations,
cultural differences between sectors and diversity of
referral routes [4, 11, 12, 14].
A recent rapid review found little good quality evi-
dence about social prescribing, largely due to a paucity
of controlled study designs [18]. However, the review
conflated the health and well-being impact of the activ-
ities themselves and the prescribing route through which
they are reached. Success is likely to relate to the inter-
action between the ways in which people are referred
and supported, the context in which referral and the ac-
tivities are offered and the needs of the people referred
as well as the health and well-being impacts of the activ-
ities to which they are referred. There is a lack of sys-
tematic consideration of the approaches used to enable
people to reach community services, to support continu-
ing participation, or whether some approaches are more
effective or cost-effective than others [4].
We plan to undertake a realist review to explain why
different methods of referral and retention in social
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prescribing activities do (or do not) work in certain cir-
cumstances for certain populations as well as the uncer-
tainties relating to methods of referral and retention
[19]. A realist review, or realist synthesis, seeks to an-
swer specified research questions by applying a realist
philosophy of science to the synthesis of relevant evi-
dence. A realist philosophy is based on the principle that
intended and unintended outcomes of interest (O) are
generated through the interaction between context (C)
and mechanism(s) (M). Consequently, what works well
for one group of people may not work at all in different
circumstances or for a different group of people [20].
The use of this method will provide understanding of
causal mechanisms and, specifically, what impacts the
social context may have on shaping the decisions made
and therefore of the outcomes of the social prescribing
process. The method has previously been used, by mem-
bers of the review team, to understand the implications
of contexts and mechanisms on the outcomes of other
forms of health promotion interventions or delivery
strategies [21–23].
Review objectives
The primary objective of this review is to explain why
different methods of referral and encouraging adherence
to social prescribing activities do (or do not) work in
certain circumstances for certain populations. The re-
view will have two phases in approaching the objectives
listed below: first, programme theories in the literature
will be identified, and second, targeted searches will be
used to seek suitable evidence to refine these theories
(see the “Methods” section).
1. What are the main factors or mechanisms2 that are
thought (both scientifically and experientially) to
explain the success or failure of social prescribing?
(We are defining success as enrolling in an activity,
turning up for the first session and continuing with
the activity, as per outcomes 1–3 below. The activity
will be deemed as failing if one or more of these
three conditions are not met.)
2. Are there methods of referral that are particularly
useful and appropriate for different groups of people
(we are particularly interested in those with mild to
moderate depression)?
3. Which approaches to referral are likely to be
appropriate, or inappropriate, within NHS primary
care settings?
4. What is the best practice for people with mild to
moderate depression to receive nature-based
interventions? (By this, we mean any intervention
which occurs in the natural environment where, for
example, greater benefits have been shown to accrue
compared to similar activities indoors [24, 25]).
Methods
As we will explore the complex nature of social prescrip-
tions, the methods of the realist review methodology are
most suitable [19]. Realist approaches try to understand,
by seeking to explain causation and how causal mecha-
nisms are shaped and constrained by the social context,
“What works, how, why, for whom, to what extent and
in what circumstances, in what respect and over what
duration?” Realist reviews usefully draw on evidence
from a wider range of sources than traditional systematic
reviews.
Search strategy
Initial scoping searches will be conducted to develop fa-
miliarity with the various models of social prescribing
relevant to NHS primary care settings. Subsequently, it-
erative and progressively more focussed searches will
then be used through two main phases.
First (a) is the identification of programme theories,
which will be used to illustrate how approaches to social
prescribing are thought to work for different groups of
people in different contexts. Since remaining involved in
the activity is important, as well as being referred to it,
we will consider contextual factors such as the suitability
and acceptability of the types of activity to which people
are referred. We will use this range of candidate theories
to develop a series of “if, then” statements around mech-
anisms which we will refine through discussion.
Second (b), following the development of key programme
theories, targeted searches will be undertaken to seek evi-
dence suitable to refine these candidate theories.
Search terms for (a) will focus on types of prescribing
models and also the setting (e.g. GP, community pro-
vider). Search terms for (b) will depend on the results
from the first phase and will be discussed both within
the review team and the broader expert advisory group
for sense-checking and completeness.
Electronic databases to be searched in both phases will
be as follows:
 MEDLINE
 Embase
 CINAHL
 GreenFILE
 PsycInfo
The purpose of the searches is not to be exhaustive,
but rather to purposively identify a range of models
which, coupled with the fact that we anticipate the lit-
erature for this topic to be diverse and dispersed, means
we will use extensive searching of grey sources. The
precise approach will develop alongside the project, how-
ever we anticipate using top-level website searches (poten-
tial models might be provided by The Conservation
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Volunteers, National Trust, Natural England and others),
selected organisation contacts through the expert advisory
group, and searches of, for example, OpenGrey.
We will also undertake forward and backward citations
chasing on included studies, hand-searching of key jour-
nals, and study author contact at both stages where
appropriate.
Study inclusion criteria
In order to develop a clear picture of the range of ways
in which social prescriptions might operate, we will in-
clude evidence, in the initial phase (a—as above), which
is of relevance and contributes to theory building and
testing through provisions of descriptions of how poten-
tial participants are identified, nature of referral model,
people involved in the referral model, context for refer-
ral, nature and type of support offered following referral
and so on. These sources of evidence are likely to in-
clude but not limited to editorials, opinion pieces, com-
munications, primary studies, process evaluations and
systematic reviews. Screening will likely be iterative, with
disagreements providing articulation of study richness
and relevance, on which prioritisation of studies will be
based should it be required.
Population inclusion criteria
In the second phase (b), we will include any studies
which include adults (>18) in a primary care setting. By
primary care, we incorporate community mental health
services, home care, community pharmacies and services
in general practices. Referral can be through any health
professional or dedicated link worker based in general
practice. Initially, we will not restrict evidence to those
with mild to moderate depression in order to obtain in-
formation on all potentially relevant social prescribing
models, but we may iteratively focus down the popula-
tion groups in response to initially identified evidence.
For example, we may focus on a group exhibiting key
personality traits associated with depression (anxiety, so-
cial isolation) where there is a particularly rich seam of
evidence.
Intervention inclusion criteria
Social prescribing programmes which have sought to
transfer patients between primary care and organisa-
tions delivering community-based activities. As above,
we will initially cast a wide net to ensure that we can
learn from all available prescribing models, including
exercise referral, arts based practice and nature-based
referrals.
Comparator
As a range of evidence and study designs will be in-
cluded, comparator criteria will only be applied to
comparative designs, for example, in randomised con-
trolled trials which compare social prescribing to a non-
social prescribing activity. Relevant comparator activities
will be those delivered within or through primary care
(i.e. patients are not referred out to a community-based
activity), and examples will be specific to conditions but
may include prescriptions for drugs, cognitive behav-
ioural therapy or physiotherapy. Only the processes of
prescription and acceptance, attendance or adherence
will be compared, rather than any effect the treatment
or intervention has on the patient’s health.
Types of study
As stated, in the first phase (a), we will include evidence
that provides descriptions of social prescribing processes;
we anticipate that important details will be provided in
non-empirical studies.
We will include, in the second phase (b), quantitative
studies including randomised controlled trials (RCTs),
controlled before-and-after studies, interrupted time
series, cohort studies and case-control studies. However,
any study providing a detailed account of a programme
will be considered.
We will include qualitative studies from any discipline
or theoretical tradition that uses recognised methods of
data collection and analysis. We will also include quali-
tative evidence linked to quantitative intervention stud-
ies (“sibling studies”).
Quantitative or qualitative process evaluations will be
included.
Where insufficient controlled evidence is located, we
will include uncontrolled studies (including, for example,
uncontrolled before-and-after studies).
Outcomes
We anticipate that the outcomes will be diverse and
context specific, and so we are unable to produce an ex-
haustive list at the outset. The outcomes will relate to
the process of social prescribing and are likely to encom-
pass the following:
1. Primary care professionals’ awareness and
prescribing of a social prescription activity and
patients’ acceptance of the prescription (enrolment)
2. Patients’ initial participation in the activity
(engagement)
3. Patient’s ongoing engagement and/or completion of
the prescription (adherence)
“Contexts” will be central to the interpretation of the
outcomes, and their impact to the firing of particular
mechanisms will be of interest to the review (physician-
led “prescription” versus patient-led “candidacy of treat-
ment”, for example).
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The effectiveness of the social prescriptions activities on
health outcomes will not be considered in this review.
We will explore relevant outcome measures with our
expert advisory group and with the full-review team.
Selection of studies
Titles and abstracts (where available) will be screened by
one reviewer, and where these appear to fit the inclusion
criteria, the full text will be screened by two reviewers.
Disagreements will be resolved through discussion and,
where required, a third reviewer.
Quality assessment
We will assess the rigour (i.e. whether the method used
to generate that particular piece of data is credible and
trustworthy) of relevant evidence in the following ways:
in the first phase (a) and in keeping with other realist re-
views, we will use a hybrid classification tool in the first
instance [26], which classifies studies as either conceptu-
ally rich, thick, or thin.
In the second phase (b), we will use standard quality
assessment tools suitable to judge the plausibility and
coherence of the method used to generate data in the in-
cluded studies. For randomised studies, we will use the
Cochrane Collaboration’s tool for assessing risk of bias
[27], and for non-randomised studies and qualitative
studies, we will use the Wallace criteria [28] for asses-
sing both reporting and methodological standards.
Appraisal of studies at both stages will be undertaken
by two reviewers independently, with any disagreement
being resolved through discussion and where necessary a
third reviewer.
Data extraction
The exported files from the searching will be uploaded
and de-duplicated in Endnote X7 [29]. Searches will be
recorded using the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [30].
In the first phase (a), data will not be formally
“extracted” but rather, in keeping with a realist approach
[26], the review team will engage with the evidence
through note-taking, annotation and discussion. Specif-
ically, we will examine the processes of social prescribing
for health and well-being and factors contributing to
success. These processes will help develop programme
theory. The data extraction process will be continually
refined based on these discussions between the review
team and the themes emerging from the included
studies. We will organise and analyse data at this stage,
if appropriate, using NVivo 10 software [31].
The second phase (b) will build on the first phases to
ensure relevant data is captured and, in method, will
constitute more traditional data extraction. Data will be
extracted into bespoke forms developed for the review.
Data will be extracted by one reviewer and checked by
another. We will extract data which helps clarify and
explain the mechanisms and refine programme the-
ory. Extracted data will likely relate to full details of
the nature of the programme (prescription process,
information given, activity, time frame and frequency
of engagement) and any theory informing it, setting/
provider, and outcomes.
Expert advisory group
An expert advisory group will be convened to check our
approaches and to develop “everyday” theories about
how social prescribing is thought to work, or not work,
in different contexts for different groups of people. This
advisory group will meet at least once in person over the
course of the project. It will comprise general practice
staff involved in social prescribing, community/third
sector groups providing activities that are socially pre-
scribed and specialist academics in the field.
Synthesis
We aim to build an understanding of the process of so-
cial prescribing by identifying how specific outcomes are
generated by relevant mechanisms which are triggered
in particular contexts. We will seek recurring patterns
across the data.
We will use the same approach to synthesis for
both phases (a) and (b), following the realist method-
ology [21, 32]:
a) Juxtaposition of sources of evidence—for example,
where evidence about implementation in one source
enables insights into evidence about outcomes in
another source.
b) Reconciling of sources of evidence—where results
differ in apparently similar circumstances; further
investigation is appropriate in order to find
explanations for why these different results
occurred.
c) Adjudication of sources of evidence—on the basis of
methodological strengths or weaknesses.
d) Consolidation of sources of evidence—where
evidence about mechanisms and outcomes is
complementary and enables a multi-faceted
explanation to be built.
e) Situating sources of evidence—where outcomes
differ in particular contexts; an explanation can be
constructed of how and why these outcomes occur
differently.
We will organise studies according to mechanism and
contextual factors such as type of activities, type of par-
ticipants, modes of referral and support. We will further
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explore mechanisms and complex outcomes through
tabulation of data and, where appropriate, through the
derivation and iterative development of a conceptual
framework/logic model [33]. We will ensure that the
limitations of the methods used to generate included
evidence are identified and taken into consideration
throughout the synthesis. Transparency will be ensured
by documenting the synthesis approach and process.
Dissemination
We will submit the results of the review to a high-
impact, peer-reviewed journal. Any write-up will
follow the Realist And Meta-narrative Evidence
Syntheses: Evolving Standards (RAMESES) publication
guidelines [20].
We will also produce a briefing document for commis-
sioners outlining our findings. This will be a two-page
summary of the purpose, aims, findings, and implica-
tions of the review that are relevant and user-friendly for
the commissioners’ respective organisations.
In addition, the findings will help to refine an interven-
tion model about nature-based interventions (NatureScript)
for those with mild to moderate depression. This approach
is being offered by a number of GPs in the South West
under the Dose of Nature scheme, as well as through other
third sector providers, such as the Conservation Trust’s
Green Gym.
Endnotes
1“Social prescribing” might refer to “non-healthcare”
interventions addressing a range of social and health
problems and may be social in nature (e.g. groups) but
could also be activities aiming to increase connectedness
with place and/or activity as well as people.
2Mechanisms are conceptualised here as the way in
which a programme’s resources or opportunities interact
with the reasoning of individuals and lead to changes in
behaviour. These relate to or are synonymous with
“intervention functions” [34].
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